Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29527648 | 1.00 | SMN1; SMN2 (0.42) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL16694568 | 0.98 | CA1 (0.43) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL29527801 | 0.98 | CA1 (0.43) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL30829086 | 0.96 | CA1 (0.41) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL17239656 | 0.94 | SMN1; SMN2 (0.38) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL28824636 | 0.94 | SMN1; SMN2 (0.38) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL17240343 | 0.92 | CA12 (0.38) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL1291696 | 0.87 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNAHPGDTSHRKMT2A | |
| SCHEMBL30821692 | 0.87 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNAHPGDTSHRKMT2A | |
| SCHEMBL30217868 | 0.86 | ABCB1 (0.40) | SMN1; SMN2LMNANPSR1ALDH1A1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12213376-B2 | Organic photoelectric conversion material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-01-28 | — | — | US | disclosed |
| US-20220310939-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-09-29 | — | — | US | disclosed |
| EP-4024486-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2022-07-06 | — | — | EP | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| EP-2871198-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-9453103-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-09-27 | — | — | US | disclosed |
| EP-2583958-A1 | Ligands for metals and improved metal-catalyzed processes based thereon | Massachusetts Institute of Technology (MIT) (US) | 2013-04-24 | — | — | EP | disclosed |
| US-7560582-B2 | Ligands for metals and improved metal-catalyzed processes based thereon | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-07-14 | — | — | US | disclosed |
| US-20080033171-A1 | Ligands for Metals and Improved Metal-Catalyzed Processes Based Thereon | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-02-07 | — | — | US | disclosed |
| US-7223879-B2 | Ligands for metals and improved metal-catalyzed processes based thereon | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-05-29 | — | — | US | disclosed |
| EP-1199303-B1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL CO (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6784321-B2 | 1-((2-ARYLSULFONYL)(3-METHYL)(5-OXY)PENT-3-ENE)-2,6,6-TRIMETHY LCYCLOHEX-1-ENE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-08-31 | — | — | US | disclosed |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-04-29 | — | — | US | disclosed |
| US-6660888-B2 | A disulfone compound of given formula | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-09 | — | — | US | disclosed |
| US-20020058844-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1199303-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | SMN1; SMN2 4667/4885CA12 5/4885CA1 15/4885 |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | ADH4, ADH1B, ADH7 | SMN1; SMN2 2604/4885CA12 3476/4885CA1 3435/4885 |
| US-20080033171-A1 | Ligands for Metals and Improved Metal-Catalyzed Processes Based Thereon | THEM6, SOD1, SLC30A6 | SMN1; SMN2 4366/4885CA12 73/4885CA1 314/4885 |
| US-20020058844-A1 | Process for producing retinol and intermediate compounds for producing the same | ADH4, ADH1B, ADH7 | SMN1; SMN2 2604/4885CA12 3476/4885CA1 3435/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | SMN1; SMN2 4562/4885CA12 252/4885CA1 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.